Results 221 to 230 of about 370,033 (238)

Potential cardioprotective actions of no-releasing aspirin

Nature Reviews Drug Discovery, 2002
John L Wallace, Stefano Fiorucci
exaly  

Low‐dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta‐analysis

Journal of Internal Medicine, 2005
Gerta Rücker, S Goldfarb
exaly  

Complex roles of the old drug aspirin in cancer chemoprevention and therapy

Medicinal Research Reviews, 2019
Yangfu Jiang
exaly  

Simultaneous Application of Photothermal Therapy and an Anti‐inflammatory Prodrug using Pyrene–Aspirin‐Loaded Gold Nanorod Graphitic Nanocapsules

Angewandte Chemie - International Edition, 2018
Zhuo Chen, Xiaoxiao Hu, Langqiu Xiao
exaly  

EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity

Allergy: European Journal of Allergy and Clinical Immunology, 2007
Marek L Kowalski, Claus Bachert, Stefan Woehrl   +2 more
exaly  

Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice

Aging Cell, 2008
Randy Strong, Richard A Miller, Christiaan Leeuwenburgh   +2 more
exaly  

Aspirin and colorectal cancer: the promise of precision chemoprevention

Nature Reviews Cancer, 2016
Yin Cao, Andrew T Chan
exaly  

Aspirin inhibits inflammation and scar formation in the injury tendon healing through regulating JNK/STAT‐3 signalling pathway

Cell Proliferation, 2019
Hongji Li, Gang He, Hong Tang
exaly  

The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetes

Journal of Thrombosis and Haemostasis, 2012
Francesco Zaccardi, Carmine Cardillo, Massimiliano Mirabella   +2 more
exaly  

Long‐term use of low‐dose aspirin for cancer prevention: A 10‐year population cohort study in Hong Kong

International Journal of Cancer, 2019
Kelvin Tsoi, Joseph J Y Sung, Krishnan Anand   +2 more
exaly